# Smith & Nephew to acquire Osiris Therapeutics for $660M

Smith & Nephew agreed to buy Osiris Therapeutics for about $660 million in cash to gain regenerative skin and wound products.

- Type: Acquisition
- Announced: 2019-03-12
- Where: Columbia, Maryland, United States
- Value: $660.0M
- Status: announced
- Products: regenerative skin and wound products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Smith & Nephew](https://endata.com/companies/19873.md) (acquirer)
- [Osiris Therapeutics](https://endata.com/companies/37964.md) (target)
- [Leaf Healthcare](https://endata.com/companies/38403.md) (target)

## Sources

- [news.bloomberglaw.com](https://news.bloomberglaw.com/pharma-and-life-sciences/smith-nephew-to-buy-osiris-in-660-million-skin-products-deal), 2019-03-12: "Smith & Nephew Plc agreed to buy Osiris Therapeutics Inc. for about $660 million in cash to gain regenerative skin and wound products."
- [innovahealthpartners.com](https://www.innovahealthpartners.com/interests/smith-nephew-announces-two-acquisitions/), 2019-03-13: "Smith & Nephew announced they would augment their regenerative medicine and wound healing portfolio with the acquisition of Osiris Therapeutics."
- [sec.gov](https://www.sec.gov/Archives/edgar/data/845982/000165495419003738/a5833u.htm), 2019-04-01: "Smith & Nephew plc today announces that it has agreed to acquire Leaf Healthcare, Inc."
- [smith-nephew.com](https://www.smith-nephew.com/en/news/2019/04/17/20190417-sn-completes-acquisition-of-osiris-therapeutics-inc), 2019-04-17: "The acquisition is expected to accelerate growth from Smith & Nephew’s Advanced Wound Management franchise."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.